Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“We anticipate that we will be able to make MDMA-assisted psychotherapy for PTSD into a legal prescription treatment in Europe through the EMA for approximately one-third the cost of the FDA program.”
· Annual Financial Report Winter 2018 (MAPS Bulletin Vol. 28, No. 3) · own post

Cost expectation for the EMA program because EMA will accept FDA data as confirmatory and require one additional Phase 3 study.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.